Suppr超能文献

相似文献

1
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):E4698-707. doi: 10.1073/pnas.1311120110. Epub 2013 Nov 19.
2
Microfabrication of a platform to measure and manipulate the mechanics of engineered microtissues.
Methods Cell Biol. 2014;121:191-211. doi: 10.1016/B978-0-12-800281-0.00013-0.
4
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes.
Nat Methods. 2013 Aug;10(8):781-7. doi: 10.1038/nmeth.2524. Epub 2013 Jun 23.
6
Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function.
Biomaterials. 2011 Dec;32(35):9180-7. doi: 10.1016/j.biomaterials.2011.08.050. Epub 2011 Sep 8.
7
Isolation and characterization of ventricular-like cells derived from NKX2-5 and MLC2v double knock-in human pluripotent stem cells.
Biochem Biophys Res Commun. 2018 Jan 1;495(1):1278-1284. doi: 10.1016/j.bbrc.2017.11.133. Epub 2017 Nov 22.
8
Functional arrays of human pluripotent stem cell-derived cardiac microtissues.
Sci Rep. 2020 Apr 24;10(1):6919. doi: 10.1038/s41598-020-62955-3.

引用本文的文献

1
Geometrically controlled cardiac microtissues promote vascularization and reduce inflammation and .
Cell Biomater. 2025 May 27;1(4). doi: 10.1016/j.celbio.2025.100075. Epub 2025 Apr 29.
2
Application of human cardiac organoids in cardiovascular disease research.
Front Cell Dev Biol. 2025 Mar 31;13:1564889. doi: 10.3389/fcell.2025.1564889. eCollection 2025.
4
Organ-on-a-Chip Applications in Microfluidic Platforms.
Micromachines (Basel). 2025 Feb 10;16(2):201. doi: 10.3390/mi16020201.
5
Heart-on-a-chip: a revolutionary organ-on-chip platform for cardiovascular disease modeling.
J Transl Med. 2025 Jan 30;23(1):132. doi: 10.1186/s12967-024-05986-y.
6
Microfluidic platforms for monitoring cardiomyocyte electromechanical activity.
Microsyst Nanoeng. 2025 Jan 9;11(1):4. doi: 10.1038/s41378-024-00751-z.
8
Motion Sensing by a Highly Sensitive Nanogold Strain Sensor in a Biomimetic 3D Environment.
ACS Appl Mater Interfaces. 2024 Oct 23;16(42):56599-56610. doi: 10.1021/acsami.4c08105. Epub 2024 Sep 10.
9
Emerging technologies for cardiac tissue engineering and artificial hearts.
Smart Med. 2023 Feb 16;2(1):e20220040. doi: 10.1002/SMMD.20220040. eCollection 2023 Feb.
10
Standardizing designed and emergent quantitative features in microphysiological systems.
Nat Biomed Eng. 2024 Aug;8(8):941-962. doi: 10.1038/s41551-024-01236-0. Epub 2024 Aug 26.

本文引用的文献

1
Topological and electrical control of cardiac differentiation and assembly.
Stem Cell Res Ther. 2013 Feb 14;4(1):14. doi: 10.1186/scrt162.
2
Mesenchymal stem cell-cardiomyocyte interactions under defined contact modes on laser-patterned biochips.
PLoS One. 2013;8(2):e56554. doi: 10.1371/journal.pone.0056554. Epub 2013 Feb 13.
3
Computational investigation of in situ chondrocyte deformation and actin cytoskeleton remodelling under physiological loading.
Acta Biomater. 2013 Apr;9(4):5943-55. doi: 10.1016/j.actbio.2012.12.021. Epub 2012 Dec 24.
5
Numerical investigation of the active role of the actin cytoskeleton in the compression resistance of cells.
J Mech Behav Biomed Mater. 2012 Oct;14:143-57. doi: 10.1016/j.jmbbm.2012.05.016. Epub 2012 Jun 21.
6
Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.
Circ Res. 2012 Oct 12;111(9):1125-36. doi: 10.1161/CIRCRESAHA.112.273144. Epub 2012 Aug 21.
9
Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):E1848-57. doi: 10.1073/pnas.1200250109. Epub 2012 May 29.
10
Vascular endothelial growth factor secretion by nonmyocytes modulates Connexin-43 levels in cardiac organoids.
Tissue Eng Part A. 2012 Sep;18(17-18):1771-83. doi: 10.1089/ten.TEA.2011.0468. Epub 2012 Aug 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验